South Korea · Delayed Price · Currency is KRW Ildong Pharmaceutical Statistics
Total Valuation
KRX:249420 has a market cap or net worth of KRW 946.82 billion. The enterprise value is 1.04 trillion.
| Market Cap | 946.82B |
| Enterprise Value | 1.04T |
Important Dates
The last earnings date was Thursday, October 30, 2025.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:249420 has 31.51 million shares outstanding. The number of shares has increased by 2.14% in one year.
| Current Share Class | 31.51M |
| Shares Outstanding | 31.51M |
| Shares Change (YoY) | +2.14% |
| Shares Change (QoQ) | +7.32% |
| Owned by Insiders (%) | 2.11% |
| Owned by Institutions (%) | 3.10% |
| Float | 20.60M |
Valuation Ratios
The trailing PE ratio is 30.63.
| PE Ratio | 30.63 |
| Forward PE | n/a |
| PS Ratio | 1.64 |
| PB Ratio | 4.05 |
| P/TBV Ratio | 4.54 |
| P/FCF Ratio | 141.83 |
| P/OCF Ratio | 45.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.34, with an EV/FCF ratio of 156.47.
| EV / Earnings | 37.41 |
| EV / Sales | 1.81 |
| EV / EBITDA | 24.34 |
| EV / EBIT | 55.28 |
| EV / FCF | 156.47 |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.66.
| Current Ratio | 0.94 |
| Quick Ratio | 0.48 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 3.63 |
| Debt / FCF | 23.28 |
| Interest Coverage | 1.34 |
Financial Efficiency
Return on equity (ROE) is 10.56% and return on invested capital (ROIC) is 3.14%.
| Return on Equity (ROE) | 10.56% |
| Return on Assets (ROA) | 2.01% |
| Return on Invested Capital (ROIC) | 3.14% |
| Return on Capital Employed (ROCE) | 5.55% |
| Revenue Per Employee | 542.56M |
| Profits Per Employee | 26.32M |
| Employee Count | 1,061 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 3.76 |
Taxes
In the past 12 months, KRX:249420 has paid 606.45 million in taxes.
| Income Tax | 606.45M |
| Effective Tax Rate | 2.81% |
Stock Price Statistics
The stock price has increased by +151.64% in the last 52 weeks. The beta is 1.07, so KRX:249420's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +151.64% |
| 50-Day Moving Average | 26,479.00 |
| 200-Day Moving Average | 17,680.15 |
| Relative Strength Index (RSI) | 56.58 |
| Average Volume (20 Days) | 4,188,948 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:249420 had revenue of KRW 575.66 billion and earned 27.92 billion in profits. Earnings per share was 980.97.
| Revenue | 575.66B |
| Gross Profit | 222.90B |
| Operating Income | 18.75B |
| Pretax Income | 21.56B |
| Net Income | 27.92B |
| EBITDA | 42.77B |
| EBIT | 18.75B |
| Earnings Per Share (EPS) | 980.97 |
Balance Sheet
The company has 59.74 billion in cash and 155.42 billion in debt, giving a net cash position of -95.69 billion or -3,036.97 per share.
| Cash & Cash Equivalents | 59.74B |
| Total Debt | 155.42B |
| Net Cash | -95.69B |
| Net Cash Per Share | -3,036.97 |
| Equity (Book Value) | 234.06B |
| Book Value Per Share | 7,727.40 |
| Working Capital | -13.82B |
Cash Flow
In the last 12 months, operating cash flow was 20.93 billion and capital expenditures -14.26 billion, giving a free cash flow of 6.68 billion.
| Operating Cash Flow | 20.93B |
| Capital Expenditures | -14.26B |
| Free Cash Flow | 6.68B |
| FCF Per Share | 211.87 |
Margins
Gross margin is 38.72%, with operating and profit margins of 3.26% and 4.85%.
| Gross Margin | 38.72% |
| Operating Margin | 3.26% |
| Pretax Margin | 3.74% |
| Profit Margin | 4.85% |
| EBITDA Margin | 7.43% |
| EBIT Margin | 3.26% |
| FCF Margin | 1.16% |
Dividends & Yields
KRX:249420 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.22% |
| Buyback Yield | -2.14% |
| Shareholder Yield | -2.14% |
| Earnings Yield | 2.95% |
| FCF Yield | 0.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 5, 2020. It was a forward split with a ratio of 1.05.
| Last Split Date | Mar 5, 2020 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
KRX:249420 has an Altman Z-Score of 2.06 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.06 |
| Piotroski F-Score | 6 |